Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2007

View Archived Issues

Recent patents impart new therapeutic agents for cancer

Recent patents disclose new agents for metabolic disorders

Novel treatment option for respiratory disorders claimed in recent Argenta patent

MEND-CABG II study of MC-1 recommended to continue

CollaGenex discontinues 40 mg cohort in phase II acne study of incyclinide

COSTAR II study fails to meet endpoints

New data indicate Homspera may demonstrate adjuvant capabilities

TorreyPines to sell assets for treating autoimmune diseases to CalciMedica

New bioavailability data for BEMA Fentanyl

Australian TGA accepts Solbec's development plan for Coramsine

Interim three-month data for ISA-247 kidney transplant trial

Preliminary phase IIa data indicate utility of AT-1001 in celiac disease

New data on NX-1207 show sustained symptomatic improvement in BPH

AEterna Zentaris updates clinical progress

European CHMP recommends approval of Siklos

TRPV1 channel as a novel drug target in ocular disorders

Recent clinical data on intravitreal bevacizumab in ophthalmological conditions

Calcineurin inhibitor-free regimen with CP-690550 effective in renal transplantation

Studies show efficacy of lamotrigine in epilepsy

Abatacept associated with reduced flare incidence in juvenile idiopathic arthritis

Vision maintained with combretastatin A-4 in choroidal neovascularization patients

SRI International regains rights to tirapazamine from sanofi-aventis

Omrix seeks Swedish approval for HBIG product

New licensing agreement for NM-702 for arteriosclerosis obliterans

AEterna Zentaris regains rights for cetrorelix from Solvay

Fabre-Kramer amends NDA for gepirone ER in major depressive disorder

Adverse event reported in phase II anemia trial of FG-2216

PAC-113 active in the treatment of oral Candida infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...